Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,3.5232248230337684e-50,32.327483898979665,3681.12664557382,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPL23', 'RPS5', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL26', 'RPL29', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",1.581927945542162e-47,0,0,61
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,4.295568752729398e-18,8.865672158982623,354.528900336719,"['COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'UCP1', 'NDUFB2', 'ATP5MC3', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA7', 'NDUFA6', 'NDUFA4', 'NDUFA1', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5', 'SLC25A4']",9.643551849877498e-16,0,0,35
3,Nonalcoholic fatty liver disease WP4396,9.918684308281729e-10,4.145239873395213,85.93675295318032,"['NDUFA13', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'LEPR', 'UQCRFS1', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA4', 'NDUFA1', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'LEP', 'CYCS', 'BAX']",1.4844964181394986e-07,0,0,32
4,Mitochondrial CIV Assembly WP4922,1.1008817022302251e-08,10.26876876876877,188.17076531645708,"['COA3', 'COX7B', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'HIGD1A', 'COX5B', 'COX7C', 'PET117', 'COX6B1', 'SCO2', 'COX14']",1.2357397107534277e-06,0,0,14
5,Oxidative phosphorylation WP623,3.966185939617028e-08,6.612014453477868,112.68774132697432,"['ATP5PF', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'ATP6AP1', 'NDUFB10', 'NDUFB5', 'NDUFA4', 'ATP6AP2', 'NDUFB2', 'ATP5MC3', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5MF', 'ATP5ME']",3.561634973776091e-06,0,0,17
6,"GPCRs, Class A Rhodopsin-like WP455",2.6239094671110576e-07,3.551034775309801,53.81035789780364,"['GPR87', 'OPRL1', 'FPR3', 'ADRA1D', 'MCHR1', 'MC4R', 'GPR171', 'RHO', 'DRD3', 'P2RY12', 'P2RY13', 'HTR1E', 'P2RY14', 'OR2H2', 'F2R', 'GPR3', 'SSTR1', 'GPR6', 'HCRTR2', 'TRHR', 'HCRTR1', 'MAS1', 'OPN1SW', 'LPAR6', 'ACKR4', 'NMUR2', 'GPR18']",1.963558917888108e-05,0,0,27
7,Mitochondrial complex III assembly WP4921,3.508562369449022e-05,11.487802148612355,117.83864743352511,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",0.0022504921484037296,0,0,7
8,Mitochondrial complex I assembly model OXPHOS system WP4324,0.00015333561088313788,4.156096175691026,36.50250022896643,"['NDUFA13', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFS6', 'NDUFB11', 'NDUFB5', 'NDUFS5', 'NDUFB3', 'NDUFB2', 'NDUFA1']",0.008605961160816113,0,0,12
9,Peptide GPCRs WP24,0.0007035111028864685,3.9823731026603557,28.909746424022543,"['MC4R', 'C5AR1', 'OPRL1', 'TAC4', 'FPR3', 'SSTR1', 'TSHR', 'HCRTR2', 'TRHR', 'HCRTR1']",0.03204179459453743,0,0,10
10,Sleep regulation WP3591,0.0007136257148003882,5.001536098310292,36.23688897582239,"['AHCY', 'IL18', 'CRH', 'GHRL', 'FOS', 'DRD3', 'HCRTR2', 'HCRTR1']",0.03204179459453743,0,0,8
11,Glycolysis and Gluconeogenesis WP534,0.0011225891150008446,4.075954847688264,27.68436446109665,"['LDHA', 'TPI1', 'GOT1', 'PGAM1', 'PGK1', 'ALDOC', 'ALDOB', 'ENO2', 'ALDOA']",0.045822046603216295,0,0,9
12,Cori Cycle WP1946,0.0014349322337065167,8.190907059874888,53.622900585009226,"['LDHA', 'TPI1', 'PGAM1', 'PGK1', 'ALDOA']",0.053690381077852165,0,0,5
13,EDA signaling in hair follicle development WP3930,0.0037809968900851974,8.730357142857143,48.69590300343467,"['SOSTDC1', 'LTB', 'DKK1', 'RELB']",0.1305898156652503,0,0,4
14,Computational Model of Aerobic Glycolysis WP4629,0.005609616572461154,7.4826530612244895,38.784632899228235,"['LDHA', 'TPI1', 'PGK1', 'ALDOA']",0.17990841721678988,0,0,4
15,Complement system WP2806,0.013697222345320897,2.3290873257397906,9.993094075769363,"['SELP', 'FKBP2', 'SELPLG', 'RPS19', 'SELL', 'F12', 'C5AR1', 'C4BPA', 'MASP2', 'CD59', 'SELE']",0.39207405715528865,0,0,11
16,Galanin receptor pathway WP4970,0.014334009837959547,5.236785714285714,22.23078510719277,"['POMC', 'CDKN1A', 'UCP1', 'FOS']",0.39207405715528865,0,0,4
17,Proximal tubule transport WP4917,0.014844674769799348,2.7607998490850783,11.623282315056663,"['SLC22A6', 'SLC7A9', 'SLC3A1', 'ATP6V0A4', 'ATP6V1E1', 'SLC5A2', 'SLC22A8', 'ATP6V1B1']",0.39207405715528865,0,0,8
18,Tamoxifen metabolism WP691,0.021807735162003117,6.5419268510258695,25.02607933546561,"['CYP2C19', 'CYP3A4', 'CYP3A5']",0.5223015501229403,0,0,3
19,Metapathway biotransformation Phase I and II WP702,0.023140669102150423,1.8765941002189874,7.067560471493466,"['CHST9', 'GPX4', 'GLYAT', 'CYP2C19', 'CYP3A4', 'CYP2C18', 'CYP3A5', 'CYP39A1', 'SULT1C2', 'CYP26B1', 'CHST13', 'GAL3ST2', 'NAT8L', 'SULT4A1', 'SULT1C4']",0.5223015501229403,0,0,15
20,Serotonin and anxiety WP3947,0.023265102455364825,4.363392857142857,16.409851303586386,"['POMC', 'ARC', 'CRH', 'FOS']",0.5223015501229403,0,0,4
21,Thyroxine (Thyroid Hormone) Production WP1981,0.02755283018002862,13.075757575757576,46.963544955893205,"['CGA', 'TSHR']",0.5891057500396595,0,0,2
22,Tryptophan metabolism WP465,0.03093395874328409,2.806989522105801,9.756816873042043,"['TPH1', 'HAAO', 'DHCR24', 'CYP3A4', 'CYP2C18', 'ACMSD']",0.6174546416139397,0,0,6
23,Circadian rhythm related genes WP3594,0.033479334189265526,1.6536393874921338,5.617126788031715,"['EGR1', 'TPH1', 'MAGEL2', 'EGR3', 'AHCY', 'CAVIN3', 'BHLHE41', 'OPRL1', 'CARTPT', 'HCRTR2', 'RELB', 'HCRTR1', 'PER2', 'LEP', 'BHLHE40', 'CRH', 'GHRL', 'RPS27A', 'DRD3']",0.6174546416139397,0,0,19
24,Kynurenine Pathway and links to Cellular Senescence WP5044,0.034942090648353324,3.7395408163265307,12.542656015113893,"['CDKN1A', 'HAAO', 'KMO', 'ACMSD']",0.6174546416139397,0,0,4
25,Prader-Willi and Angelman Syndrome WP3998,0.03601259666279457,2.2794140564126537,7.576513597322692,"['POMC', 'PCSK1', 'MAGEL2', 'CDKN2B', 'BDNF', 'GHRL', 'CGA', 'TYR']",0.6174546416139397,0,0,8
26,Farnesoid X receptor pathway WP2879,0.03850496651490047,4.905776092774309,15.977955973138386,"['SLC10A1', 'CYP3A4', 'FKBP5']",0.6174546416139397,0,0,3
27,Glycolysis in senescence WP5049,0.03850496651490047,4.905776092774309,15.977955973138386,"['LDHA', 'PGK1', 'ALDOC']",0.6174546416139397,0,0,3
28,Sulfation Biotransformation Reaction WP692,0.03850496651490047,4.905776092774309,15.977955973138386,"['SULT1C2', 'SULT4A1', 'SULT1C4']",0.6174546416139397,0,0,3
29,Vitamin D Receptor Pathway WP2877,0.04060620107109921,1.766857241857242,5.660718167357789,"['CDKN1A', 'CDKN2B', 'COL13A1', 'GADD45A', 'CYP3A4', 'CYP3A5', 'SULT1C2', 'CEACAM1', 'S100A6', 'TIMP2', 'TIMP3', 'SOSTDC1', 'LGALS9', 'JUNB']",0.6262470484881669,0,0,14
30,Inflammatory Response Pathway WP453,0.041842787204109146,3.49,11.07668710137858,"['COL1A1', 'IL5', 'CD80', 'FN1']",0.6262470484881669,0,0,4
31,Oxidation by Cytochrome P450 WP43,0.04470129829340154,2.5348260141958567,7.87761247377648,"['CYP39A1', 'CYP26B1', 'CYP3A4', 'CYP2C19', 'CYP3A5', 'CYP2C18']",0.6270037217610265,0,0,6
32,Platelet-mediated interactions with vascular and circulating cells WP4462,0.04869144325774188,4.360392506690455,13.178204832232803,"['SELP', 'SELPLG', 'SELE']",0.6270037217610265,0,0,3
33,Serotonin and anxiety-related events WP3944,0.04869144325774188,4.360392506690455,13.178204832232803,"['ARC', 'CRH', 'FOS']",0.6270037217610265,0,0,3
34,Vitamin A and carotenoid metabolism WP716,0.0500174268697907,2.4554449910554563,7.355000140345591,"['ALDH1A3', 'CYP26B1', 'RBP2', 'NPC1L1', 'LPL', 'LRAT']",0.6270037217610265,0,0,6
35,Selenium Micronutrient Network WP15,0.05085798018575058,1.9993311545185073,5.9554441637580195,"['SELENOM', 'PRDX5', 'GPX4', 'RFK', 'SELENOW', 'KMO', 'SEPHS2', 'SELENOH', 'MSRB1']",0.6270037217610265,0,0,9
36,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.05185533627431163,2.0964874551971326,6.204129942521145,"['CDKN1A', 'TMSB4X', 'FN1', 'NEFL', 'NEFM', 'ELK1', 'NEFH', 'PFN2']",0.6270037217610265,0,0,8
37,"GPCRs, Other WP117",0.05185533627431163,2.0964874551971326,6.204129942521145,"['P2RY13', 'GPR183', 'F2R', 'GPR55', 'ADRA1D', 'OR10A2', 'DRD3', 'GPR18']",0.6270037217610265,0,0,8
38,Pregnane X receptor pathway WP2876,0.05777621273114133,3.0789915966386556,8.77875351035002,"['HSP90AA1', 'CYP2C19', 'CYP3A4', 'CYP3A5']",0.6270037217610265,0,0,4
39,Purinergic signaling WP4900,0.05777621273114133,3.0789915966386556,8.77875351035002,"['P2RY12', 'P2RY13', 'LPAR6', 'P2RY14']",0.6270037217610265,0,0,4
40,Base Excision Repair WP4752,0.05835395478167157,2.618051831992851,7.4384825518388995,"['POLE4', 'POLD4', 'FEN1', 'NEIL2', 'POLE3']",0.6270037217610265,0,0,5
41,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.05835395478167157,2.618051831992851,7.4384825518388995,"['NDUFA13', 'HSP90AA1', 'IL18', 'NLRC4', 'AAMP']",0.6270037217610265,0,0,5
42,Cysteine and methionine catabolism WP4504,0.06004712702833884,3.924085637823372,11.036983621833203,"['AHCY', 'GOT1', 'SQOR']",0.6270037217610265,0,0,3
43,Development and heterogeneity of the ILC family WP3893,0.06004712702833884,3.924085637823372,11.036983621833203,"['IL5', 'IL7', 'IL18']",0.6270037217610265,0,0,3
44,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.06260922732929991,6.53698752228164,18.11296356981643,"['IL5', 'CD80']",0.6388987061558105,0,0,2
45,Constitutive Androstane Receptor Pathway WP2875,0.06679434960545311,2.9077380952380953,7.868737031608296,"['HSP90AA1', 'CYP2C19', 'CYP3A4', 'CYP3A5']",0.66645917717441,0,0,4
46,Spinal Cord Injury WP2431,0.07413046021694988,1.7164998074701578,4.466210219180574,"['SELP', 'EGR1', 'NR4A1', 'GADD45A', 'BDNF', 'LEP', 'FOS', 'LTB', 'PDYN', 'ROS1', 'TNFSF13B']",0.7235777529871847,0,0,11
47,DNA Mismatch Repair WP531,0.07649503598985713,2.754511278195489,7.080552303875549,"['POLE4', 'POLD4', 'RPA3', 'POLE3']",0.7307717267967202,0,0,4
48,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.08177863291912463,2.3370675347887144,5.851407788622343,"['LDHA', 'ANGPT2', 'IGFBP2', 'PGK1', 'BAX']",0.742804695126107,0,0,5
49,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.08219036406096837,2.1229028670889134,5.304533927724946,"['CDKN1A', 'HSP90AA1', 'BAX', 'FOS', 'ELK1', 'JUNB']",0.742804695126107,0,0,6
50,Dual hijack model of Vif in HIV infection WP3300,0.0836058747537162,5.229233511586453,12.977082838999006,"['ELOB', 'RUNX1']",0.742804695126107,0,0,2
51,Overview of nanoparticle effects WP3287,0.0860263789455625,3.2696253345227477,8.020722151555557,"['FN1', 'HMOX1', 'BAX']",0.742804695126107,0,0,3
52,TP53 network WP1742,0.0860263789455625,3.2696253345227477,8.020722151555557,"['CDKN1A', 'GADD45A', 'BAX']",0.742804695126107,0,0,3
53,Complement and Coagulation Cascades WP558,0.08973916548661028,2.0668957725261277,4.982971493338149,"['CPB2', 'SERPIND1', 'F12', 'F2R', 'C5AR1', 'MASP2']",0.7602431189337361,0,0,6
54,IL-18 signaling pathway WP4754,0.09317287643915763,1.4062621422095583,3.33748000846401,"['SLC12A3', 'NRN1', 'CD81', 'COX17', 'FN1', 'IL18', 'FOS', 'FUT1', 'COL1A1', 'NR4A1', 'ARL4D', 'TMSB4X', 'HMOX1', 'TIMP3', 'CYCS', 'BAX', 'LTB', 'PTPN7', 'SNTB1', 'ITM2C', 'ARF6']",0.7747152133552181,0,0,21
55,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.10636133695463695,4.357397504456328,9.764549335258145,"['HSD11B1', 'HSD11B2']",0.8233834533212412,0,0,2
56,HIF1A and PPARG regulation of glycolysis WP2456,0.10636133695463695,4.357397504456328,9.764549335258145,"['LDHA', 'TPI1']",0.8233834533212412,0,0,2
57,Irinotecan pathway WP229,0.10636133695463695,4.357397504456328,9.764549335258145,"['CYP3A4', 'CYP3A5']",0.8233834533212412,0,0,2
58,NAD Biosynthesis II (from tryptophan) WP2485,0.10636133695463695,4.357397504456328,9.764549335258145,"['HAAO', 'KMO']",0.8233834533212412,0,0,2
59,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.10947766606688793,2.378409090909091,5.261123471729231,"['EGR2', 'RAB3A', 'RAB25', 'NEFL']",0.8331435943056387,0,0,4
60,Matrix Metalloproteinases WP129,0.11588640268237432,2.8021536893080157,6.0390471061839825,"['TIMP2', 'TIMP3', 'MMP19']",0.8672165800731012,0,0,3
61,Bile acids synthesis and enterohepatic circulation  WP4389,0.13051952625281138,3.7346574993633816,7.604630741117179,"['SLC10A1', 'FGFR4']",0.9123353517078973,0,0,2
62,Leptin and adiponectin WP3934,0.13051952625281138,3.7346574993633816,7.604630741117179,"['LEP', 'LEPR']",0.9123353517078973,0,0,2
63,Trans-sulfuration pathway WP2333,0.13051952625281138,3.7346574993633816,7.604630741117179,"['AHCY', 'GOT1']",0.9123353517078973,0,0,2
64,IL1 and megakaryocytes in obesity WP2865,0.13207527363254637,2.6151650312221233,5.29409632216297,"['F2R', 'IL18', 'TIMP2']",0.9123353517078973,0,0,3
65,Nanomaterial induced apoptosis WP2507,0.13207527363254637,2.6151650312221233,5.29409632216297,"['ENDOG', 'BAX', 'CYCS']",0.9123353517078973,0,0,3
66,Heart Development WP1591,0.14768866455442195,2.0925714285714285,4.002354312974748,"['HEY1', 'BHLHE40', 'SMYD1', 'FGF10']",0.9993770810362673,0,0,4
67,Endometrial cancer WP4155,0.14993727376617552,1.6655977862781801,3.1605355039770373,"['CDKN1A', 'GADD45B', 'GADD45A', 'BAX', 'FOS', 'FGF1', 'ELK1']",0.9993770810362673,0,0,7
68,ACE Inhibitor Pathway WP554,0.15576604734390018,3.267602495543672,6.075780387095563,"['MAS1', 'ATP6AP2']",0.9993770810362673,0,0,2
69,Cytokines and Inflammatory Response WP530,0.15576604734390018,3.267602495543672,6.075780387095563,"['IL5', 'IL7']",0.9993770810362673,0,0,2
70,VEGFA-VEGFR2 Signaling Pathway WP3888,0.16008948566492745,1.219326214468341,2.2338328581720663,"['SET', 'RPL10A', 'ELK1', 'FUT1', 'APOLD1', 'RPL7', 'ACTG1', 'TUBB8', 'LDHA', 'RPL18A', 'ADAMTS1', 'TMSB4X', 'PGK1', 'RPLP2', 'DNAJB9', 'ATP6V1E1', 'TMSB10', 'DUSP5', 'EGR1', 'HSP90AA1', 'SDF2L1', 'EGR3', 'FN1', 'DKK1', 'SELE', 'NR4A1', 'RCN1', 'NR4A3', 'CYCS', 'RPL26', 'ALDOA', 'DSC1', 'FJX1', 'ARF6']",0.9993770810362673,0,0,34
71,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.1665594422861441,2.3071837120218293,4.135403058999624,"['H2AFZ', 'DUSP6', 'HIST1H3E']",0.9993770810362673,0,0,3
72,Melanoma WP4685,0.16837560507163854,1.6069358714602082,2.8628495386984363,"['CDKN1A', 'GADD45B', 'GADD45A', 'BAX', 'CALM3', 'FOS', 'ELK1']",0.9993770810362673,0,0,7
73,Cardiac Progenitor Differentiation WP2406,0.17561860725741243,1.9373015873015873,3.369821111948165,"['MESP1', 'THY1', 'DKK1', 'NODAL']",0.9993770810362673,0,0,4
74,Cells and molecules involved in local acute inflammatory response  WP4493,0.18182407541971293,2.9043374925727865,4.951069657662367,"['SELP', 'SELPLG']",0.9993770810362673,0,0,2
75,Transcriptional cascade regulating adipogenesis WP4211,0.18182407541971293,2.9043374925727865,4.951069657662367,"['EGR2', 'DDIT3']",0.9993770810362673,0,0,2
76,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.19966775899735706,1.3542235177375341,2.1817901848843233,"['ADCYAP1', 'EGR1', 'TPH1', 'CAV3', 'BDNF', 'KCNQ1', 'BHLHE40', 'SSTR1', 'FOXM1', 'ALDOA', 'SLC25A4', 'YWHAH']",0.9993770810362673,0,0,12
77,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.20330508948989492,2.0640405652847553,3.2881147125383525,"['SRXN1', 'HMOX1', 'FOS']",0.9993770810362673,0,0,3
78,Amyotrophic lateral sclerosis (ALS) WP2447,0.20516485268703386,1.803448275862069,2.856556501519675,"['NEFL', 'BAX', 'NEFM', 'NEFH']",0.9993770810362673,0,0,4
79,Corticotropin-releasing hormone signaling pathway WP2355,0.2079652723220168,1.4537037037037037,2.2828732888337733,"['POMC', 'NR4A1', 'HSP90AA1', 'IL18', 'CRH', 'FOS', 'ELK1', 'JUNB']",0.9993770810362673,0,0,8
80,Drug Induction of Bile Acid Pathway WP2289,0.20845060891013856,2.6137254901960785,4.098460497355256,"['SLC10A1', 'CYP3A4']",0.9993770810362673,0,0,2
81,Genes targeted by miRNAs in adipocytes WP1992,0.20845060891013856,2.6137254901960785,4.098460497355256,"['TMSB4X', 'KCNQ1']",0.9993770810362673,0,0,2
82,Iron metabolism in placenta WP2007,0.20845060891013856,2.6137254901960785,4.098460497355256,"['HEPHL1', 'FTH1']",0.9993770810362673,0,0,2
83,Pathways in clear cell renal cell carcinoma WP4018,0.227222469394401,1.4142206722851884,2.0956285377238943,"['LDHA', 'TPI1', 'BHLHE41', 'PGK1', 'ALDOC', 'ALDOB', 'ENO2', 'ALDOA']",0.9993770810362673,0,0,8
84,Pyrimidine metabolism WP4022,0.227222469394401,1.4142206722851884,2.0956285377238943,"['NT5C', 'POLE4', 'POLD4', 'POLE3', 'NME2', 'POLR2I', 'POLR2K', 'POLR2L']",0.9993770810362673,0,0,8
85,Major receptors targeted by epinephrine and norepinephrine WP4589,0.23543306442757297,2.3759520337060445,3.4364074579571033,"['ADCY10', 'ADRA1D']",0.9993770810362673,0,0,2
86,Adipogenesis WP236,0.23860227654615812,1.3350492800351739,1.9130685156927119,"['EGR2', 'CDKN1A', 'CYP26B1', 'GADD45B', 'GADD45A', 'DDIT3', 'LEP', 'UCP1', 'LPL', 'PRLR']",0.9993770810362673,0,0,10
87,Canonical and non-canonical Notch signaling WP3845,0.24167915383170446,1.8672103988785522,2.6517080986289296,"['MAML2', 'HEY1', 'DLL3']",0.9993770810362673,0,0,3
88,Differentiation Pathway WP2848,0.2518384605424836,1.6340401785714285,2.253288180024191,"['FGF1', 'DKK1', 'NODAL', 'FGF10']",0.9993770810362673,0,0,4
89,22q11.2 copy number variation syndrome WP4657,0.2523656175539123,1.3378006522625356,1.8419861187763555,"['CLDN5', 'RANBP1', 'CYP26B1', 'MRPL40', 'SERPIND1', 'THAP7', 'HIST1H4C', 'RAN', 'FGF10']",0.9993770810362673,0,0,9
90,Aflatoxin B1 metabolism WP699,0.25567121928089287,4.354407836153161,5.9388155587483915,['CYP3A4'],0.9993770810362673,0,0,1
91,COVID-19 adverse outcome pathway WP4891,0.25567121928089287,4.354407836153161,5.9388155587483915,['IL7'],0.9993770810362673,0,0,1
92,Myometrial relaxation and contraction pathways WP289,0.260950870576578,1.2661580413088884,1.700985992240389,"['RGS4', 'GNG3', 'PRKCH', 'IGFBP2', 'MAFF', 'CRH', 'CALM3', 'FOS', 'RXFP2', 'CORIN', 'ACTG1', 'YWHAH']",0.9993770810362673,0,0,12
93,Photodynamic therapy-induced unfolded protein response WP3613,0.2612905932203355,1.7822155542940556,2.3919508949032187,"['XBP1', 'DDIT3', 'DNAJB9']",0.9993770810362673,0,0,3
94,Fatty acid transporters WP5061,0.26258618465362565,2.177807486631016,2.912111747695766,"['FABP6', 'FABP7']",0.9993770810362673,0,0,2
95,ID signaling pathway WP53,0.26258618465362565,2.177807486631016,2.912111747695766,"['ELK1', 'PAX2']",0.9993770810362673,0,0,2
96,Leptin Insulin Overlap WP3935,0.26258618465362565,2.177807486631016,2.912111747695766,"['LEP', 'LEPR']",0.9993770810362673,0,0,2
97,miR-509-3p alteration of YAP1/ECM axis WP3967,0.26258618465362565,2.177807486631016,2.912111747695766,"['COL1A1', 'FN1']",0.9993770810362673,0,0,2
98,Glucocorticoid Receptor Pathway WP2880,0.265583871933524,1.4263782728899008,1.8911273836548965,"['HSP90AA1', 'MGAM', 'GADD45B', 'BHLHE40', 'SPRY1', 'ANGPTL4']",0.9993770810362673,0,0,6
99,Oxidative Damage WP3941,0.26787054243091485,1.5844155844155845,2.087073751021634,"['CDKN1A', 'GADD45A', 'C5AR1', 'CYCS']",0.9993770810362673,0,0,4
100,16p11.2 distal deletion syndrome WP4950,0.28109227878040915,1.7046115657603846,2.163275268071454,"['PLN', 'SLN', 'CD81']",0.9993770810362673,0,0,3
101,Oxidative Stress WP408,0.28109227878040915,1.7046115657603846,2.163275268071454,"['HMOX1', 'FOS', 'JUNB']",0.9993770810362673,0,0,3
102,Ferroptosis WP4313,0.2840773549283799,1.5377100840336135,1.935221520987286,"['MAP1LC3A', 'GPX4', 'FTH1', 'HMOX1']",0.9993770810362673,0,0,4
103,Hematopoietic Stem Cell Differentiation WP2849,0.2840773549283799,1.5377100840336135,1.935221520987286,"['TRAF3IP3', 'IL5', 'FOS', 'RUNX1']",0.9993770810362673,0,0,4
104,Nuclear Receptors Meta-Pathway WP2882,0.2872620997447381,1.168559135610766,1.4576142043676847,"['EGR1', 'HSP90AA1', 'GADD45B', 'SRXN1', 'SLC10A1', 'SLC5A12', 'SLC5A2', 'CYP2C19', 'CYP3A4', 'CYP3A5', 'FTH1', 'BHLHE40', 'MAFF', 'HMOX1', 'BAX', 'SPRY1', 'ANGPTL4', 'SLC39A7', 'JUNB', 'FKBP5']",0.9993770810362673,0,0,20
105,Blood Clotting Cascade WP272,0.2897492312870158,2.010146716029069,2.4900480370056193,"['F8A1', 'F12']",0.9993770810362673,0,0,2
106,ERK Pathway in Huntington's Disease WP3853,0.2897492312870158,2.010146716029069,2.4900480370056193,"['BDNF', 'ELK1']",0.9993770810362673,0,0,2
107,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.2897492312870158,2.010146716029069,2.4900480370056193,"['CD63', 'CD81']",0.9993770810362673,0,0,2
108,Hypertrophy Model WP516,0.2897492312870158,2.010146716029069,2.4900480370056193,"['NR4A3', 'IL18']",0.9993770810362673,0,0,2
109,Tryptophan catabolism leading to NAD+ production WP4210,0.2897492312870158,2.010146716029069,2.4900480370056193,"['HAAO', 'KMO']",0.9993770810362673,0,0,2
110,Monoamine GPCRs WP58,0.3010193132759148,1.6334745762711864,1.9611182994544487,"['HTR1E', 'ADRA1D', 'DRD3']",0.9993770810362673,0,0,3
111,Composition of Lipid Particles WP3601,0.30864559918104967,3.2655832591273373,3.838894243565494,['LPL'],0.9993770810362673,0,0,1
112,let-7 inhibition of ES cell reprogramming WP3299,0.30864559918104967,3.2655832591273373,3.838894243565494,['EGR1'],0.9993770810362673,0,0,1
113,miR-517 relationship with ARCN1 and USP1 WP3596,0.30864559918104967,3.2655832591273373,3.838894243565494,['CDKN1A'],0.9993770810362673,0,0,1
114,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.30864559918104967,3.2655832591273373,3.838894243565494,['MAS1'],0.9993770810362673,0,0,1
115,Genotoxicity pathway WP4286,0.31037327320528807,1.3904892286045671,1.6268440297415627,"['PLK3', 'CDKN1A', 'RPS27', 'GADD45A', 'TRIAP1']",0.9993770810362673,0,0,5
116,MAPK pathway in congenital thyroid cancer WP4928,0.3167834389601555,1.8664374840845428,2.145538752812606,"['FOS', 'ELK1']",0.9993770810362673,0,0,2
117,Small cell lung cancer WP4658,0.32036184288284214,1.2600941400008636,1.4343704053423527,"['CDKN1A', 'CDKN2B', 'LAMB3', 'GADD45B', 'GADD45A', 'FN1', 'CYCS', 'BAX']",0.9993770810362673,0,0,8
118,Aryl Hydrocarbon Receptor Pathway WP2873,0.32101069093302026,1.568028545941124,1.7817208110751526,"['HSP90AA1', 'BAX', 'JUNB']",0.9993770810362673,0,0,3
119,PPAR signaling pathway WP3942,0.3246769225413005,1.3614276139410189,1.5315035169251678,"['FABP6', 'FABP7', 'UCP1', 'LPL', 'ANGPTL4']",0.9993770810362673,0,0,5
120,Metabolic reprogramming in colon cancer WP4290,0.33339042471673697,1.4127413127413126,1.5518130215378163,"['LDHA', 'PGAM1', 'PGK1', 'ALDOB']",0.9993770810362673,0,0,4
121,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.3435697064068549,1.7418894830659537,1.8609742070657613,"['CDKN1A', 'ROS1']",0.9993770810362673,0,0,2
122,GDNF/RET signaling axis WP4830,0.3435697064068549,1.7418894830659537,1.8609742070657613,"['SPRY1', 'PAX2']",0.9993770810362673,0,0,2
123,Breast cancer pathway WP4262,0.3472696450772703,1.1787739531321344,1.2467346632308158,"['SHC4', 'CDKN1A', 'FRAT2', 'GADD45B', 'HEY1', 'GADD45A', 'BAX', 'FOS', 'FGF1', 'FGF10', 'DLL3']",0.9993770810362673,0,0,11
124,Cellular Proteostasis WP4918,0.35785286726874055,2.612288512911843,2.6844748279306736,['PFDN5'],0.9993770810362673,0,0,1
125,Codeine and Morphine Metabolism WP1604,0.35785286726874055,2.612288512911843,2.6844748279306736,['CYP3A4'],0.9993770810362673,0,0,1
126,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.35785286726874055,2.612288512911843,2.6844748279306736,['CYP2C18'],0.9993770810362673,0,0,1
127,Fatty Acid Omega Oxidation WP206,0.35785286726874055,2.612288512911843,2.6844748279306736,['CYP3A4'],0.9993770810362673,0,0,1
128,FOXP3 in COVID-19 WP5063,0.35785286726874055,2.612288512911843,2.6844748279306736,['CD80'],0.9993770810362673,0,0,1
129,FTO Obesity Variant Mechanism WP3407,0.35785286726874055,2.612288512911843,2.6844748279306736,['UCP1'],0.9993770810362673,0,0,1
130,LncRNA-mediated mechanisms of therapeutic resistance WP3672,0.35785286726874055,2.612288512911843,2.6844748279306736,['CDKN1A'],0.9993770810362673,0,0,1
131,miRNA Biogenesis WP2338,0.35785286726874055,2.612288512911843,2.6844748279306736,['RAN'],0.9993770810362673,0,0,1
132,Peroxiredoxin 2 induced ovarian failure WP4873,0.35785286726874055,2.612288512911843,2.6844748279306736,['BAX'],0.9993770810362673,0,0,1
133,Regulation of Microtubule Cytoskeleton WP2038,0.3665082421045492,1.34010989010989,1.3451142212228915,"['PARD6A', 'CFL2', 'RHO', 'PHLDB2']",0.9993770810362673,0,0,4
134,Nicotine Activity on Dopaminergic Neurons WP1602,0.37000650485389386,1.632909982174688,1.6234957545174353,"['DRD3', 'SLC18A2']",0.9993770810362673,0,0,2
135,Nucleotide metabolism WP404,0.37000650485389386,1.632909982174688,1.6234957545174353,"['NME2', 'OAZ1']",0.9993770810362673,0,0,2
136,NRF2 pathway WP2884,0.37188552474933206,1.1762959641255606,1.1635557392509632,"['EGR1', 'HSP90AA1', 'SRXN1', 'FTH1', 'MAFF', 'HMOX1', 'SLC5A12', 'SLC39A7', 'SLC5A2']",0.9993770810362673,0,0,9
137,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.3804061381700994,1.2250391323792487,1.1840196921886879,"['CDKN1A', 'GADD45B', 'GADD45A', 'CYCS', 'BAX', 'FOS']",0.9993770810362673,0,0,6
138,Nucleotide Excision Repair WP4753,0.3830465809108288,1.306517857142857,1.2537328059103134,"['POLE4', 'POLD4', 'RPA3', 'POLE3']",0.9993770810362673,0,0,4
139,Androgen receptor signaling pathway WP138,0.38971908972145586,1.1879221941889802,1.1194136309183338,"['CDKN1A', 'BAG1', 'RNF6', 'STUB1', 'FKBP4', 'ETV5', 'RAN']",0.9993770810362673,0,0,7
140,Imatinib and Chronic Myeloid Leukemia WP3640,0.39600798408327326,1.536751599035336,1.4235251336758838,"['SPRED2', 'GADD45A']",0.9993770810362673,0,0,2
141,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.39600798408327326,1.536751599035336,1.4235251336758838,"['LDHA', 'CD80']",0.9993770810362673,0,0,2
142,RAS and bradykinin pathways in COVID-19 WP4969,0.39600798408327326,1.536751599035336,1.4235251336758838,"['F12', 'CYP3A4']",0.9993770810362673,0,0,2
143,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.39600798408327326,1.536751599035336,1.4235251336758838,"['EGR1', 'ELK1']",0.9993770810362673,0,0,2
144,Oncostatin M Signaling Pathway WP2374,0.3967942460573808,1.2325695111875494,1.1393101028862527,"['EGR1', 'PRKCH', 'TIMP3', 'FOS', 'JUNB']",0.9993770810362673,0,0,5
145,BDNF-TrkB Signaling WP3676,0.4005390684086565,1.3513796179519517,1.2364366301206398,"['ARC', 'TRPC6', 'BDNF']",0.9993770810362673,0,0,3
146,CAMKK2  Pathway WP4874,0.4005390684086565,1.3513796179519517,1.2364366301206398,"['FIS1', 'MAP1LC3A', 'HMOX1']",0.9993770810362673,0,0,3
147,Benzo(a)pyrene metabolism WP696,0.4035606877883582,2.176758682101514,1.9752526462152329,['CYP3A4'],0.9993770810362673,0,0,1
148,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.4035606877883582,2.176758682101514,1.9752526462152329,['DHCR24'],0.9993770810362673,0,0,1
149,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.4035606877883582,2.176758682101514,1.9752526462152329,['HEY1'],0.9993770810362673,0,0,1
150,Nucleotide GPCRs WP80,0.4035606877883582,2.176758682101514,1.9752526462152329,['LPAR6'],0.9993770810362673,0,0,1
151,Tgif disruption of Shh signaling WP3674,0.4035606877883582,2.176758682101514,1.9752526462152329,['NODAL'],0.9993770810362673,0,0,1
152,Leptin signaling pathway WP2034,0.40636322262128177,1.1877541063587576,1.0695819350474671,"['CISH', 'CFL2', 'LEP', 'LEPR', 'BAX', 'ELK1']",0.9993770810362673,0,0,6
153,Proteasome Degradation WP183,0.41119595190716995,1.2096614040313771,1.0750084401657567,"['PSMD8', 'PSMB6', 'H2AFZ', 'HLA-C', 'PSMB10']",0.9993770810362673,0,0,5
154,Senescence and Autophagy in Cancer WP615,0.4134930766992766,1.1576895617782714,1.0223724475678784,"['COL1A1', 'GABARAPL2', 'GABARAPL1', 'CDKN1A', 'MAP1LC3A', 'FN1', 'GABARAP']",0.9993770810362673,0,0,7
155,Histone Modifications WP2369,0.4159414104573032,1.2441326530612244,1.0913666856021023,"['SET', 'SMYD1', 'HIST1H4C', 'HIST1H3E']",0.9993770810362673,0,0,4
156,Pre-implantation embryo WP3527,0.42007648368711914,1.3062444246208742,1.132929929219022,"['EGR1', 'DDIT3', 'AQP3']",0.9993770810362673,0,0,3
157,Globo Sphingolipid Metabolism WP1424,0.42150225824229154,1.4512774806892454,1.2538023627620682,"['ST6GALNAC1', 'FUT1']",0.9993770810362673,0,0,2
158,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.42150225824229154,1.4512774806892454,1.2538023627620682,"['SELE', 'RELB']",0.9993770810362673,0,0,2
159,Exercise-induced Circadian Regulation WP410,0.43224627788185754,1.2151162790697674,1.0191906452717456,"['PER2', 'HSPA8', 'CLDN5', 'BTG1']",0.9993770810362673,0,0,4
160,Estrogen metabolism WP697,0.44601772270735424,1.8656659458084213,1.50633232410462,['CYP3A4'],0.9993770810362673,0,0,1
161,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.44601772270735424,1.8656659458084213,1.50633232410462,['ELOB'],0.9993770810362673,0,0,1
162,Liver X receptor pathway WP2874,0.44601772270735424,1.8656659458084213,1.50633232410462,['CYP3A4'],0.9993770810362673,0,0,1
163,Macrophage markers WP4146,0.44601772270735424,1.8656659458084213,1.50633232410462,['CD68'],0.9993770810362673,0,0,1
164,Mitochondrial CII Assembly WP4920,0.44601772270735424,1.8656659458084213,1.50633232410462,['SDHAF1'],0.9993770810362673,0,0,1
165,Urea cycle and related diseases WP4571,0.44601772270735424,1.8656659458084213,1.50633232410462,['SLC25A15'],0.9993770810362673,0,0,1
166,Angiogenesis WP1539,0.4464298565381298,1.3748006379585327,1.10873957733419,"['TIMP2', 'TIMP3']",0.9993770810362673,0,0,2
167,Differentiation of white and brown adipocyte WP2895,0.4464298565381298,1.3748006379585327,1.10873957733419,"['LEP', 'EBF3']",0.9993770810362673,0,0,2
168,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.4464298565381298,1.3748006379585327,1.10873957733419,"['GOT1', 'SCO2']",0.9993770810362673,0,0,2
169,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.4464298565381298,1.3748006379585327,1.10873957733419,"['BAX', 'BCL2L14']",0.9993770810362673,0,0,2
170,Synaptic Vesicle Pathway WP2267,0.44842432955269623,1.1874188311688312,0.9523281065165062,"['RAB3A', 'SLC25A4', 'SLC18A2', 'AP2M1']",0.9993770810362673,0,0,4
171,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.4584620184543026,1.2244368867082962,0.9549111814687589,"['DDIT3', 'FOS', 'JUNB']",0.9993770810362673,0,0,3
172,Oxysterols derived from cholesterol WP4545,0.4584620184543026,1.2244368867082962,0.9549111814687589,"['CYP39A1', 'GPR183', 'CYP3A4']",0.9993770810362673,0,0,3
173,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.46812431904554996,1.12592832270192,0.8546036685510155,"['ANGPT2', 'TIE1', 'FN1', 'BAX', 'ANGPTL1']",0.9993770810362673,0,0,5
174,Estrogen signaling pathway WP712,0.4707423228602718,1.3059714795008912,0.9839769237703917,"['FOS', 'ELK1']",0.9993770810362673,0,0,2
175,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.4707423228602718,1.3059714795008912,0.9839769237703917,"['BDNF', 'CGA']",0.9993770810362673,0,0,2
176,Unfolded protein response WP4925,0.4707423228602718,1.3059714795008912,0.9839769237703917,"['XBP1', 'DDIT3']",0.9993770810362673,0,0,2
177,Urea cycle and associated pathways WP4595,0.4707423228602718,1.3059714795008912,0.9839769237703917,"['SLC25A15', 'GOT1']",0.9993770810362673,0,0,2
178,Zinc homeostasis WP3529,0.4707423228602718,1.3059714795008912,0.9839769237703917,"['SLC30A2', 'SLC39A7']",0.9993770810362673,0,0,2
179,MAPK Signaling Pathway WP382,0.4717460611141125,1.042533430029136,0.7832704246339708,"['DUSP4', 'HSPA8', 'DUSP2', 'GADD45A', 'DUSP1', 'BDNF', 'FOS', 'FGF1', 'ELK1', 'DUSP6', 'RELB', 'NR4A1', 'DDIT3', 'PTPN7', 'FGFR4', 'CACNG4', 'FGF10']",0.9993770810362673,0,0,17
180,DNA damage response WP707,0.48210708803939056,1.1067690583299252,0.8074865473794444,"['CDKN1A', 'GADD45B', 'GADD45A', 'CYCS', 'BAX']",0.9993770810362673,0,0,5
181,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.48210708803939056,1.1067690583299252,0.8074865473794444,"['CDKN1A', 'TRPC6', 'CD80', 'DKK1', 'PAX2']",0.9993770810362673,0,0,5
182,"Degradation pathway of sphingolipids, including diseases WP4153",0.48545497952441247,1.632346393588602,1.179645688115274,['NEU1'],0.9993770810362673,0,0,1
183,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.48545497952441247,1.632346393588602,1.179645688115274,['HMOX1'],0.9993770810362673,0,0,1
184,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.48545497952441247,1.632346393588602,1.179645688115274,['BAX'],0.9993770810362673,0,0,1
185,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.48545497952441247,1.632346393588602,1.179645688115274,['AHCY'],0.9993770810362673,0,0,1
186,PTF1A related regulatory pathway WP4147,0.48545497952441247,1.632346393588602,1.179645688115274,['FGF10'],0.9993770810362673,0,0,1
187,Role of Osx and miRNAs in tooth development WP3971,0.48545497952441247,1.632346393588602,1.179645688115274,['DKK1'],0.9993770810362673,0,0,1
188,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.48545497952441247,1.632346393588602,1.179645688115274,['DLL3'],0.9993770810362673,0,0,1
189,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.48545497952441247,1.632346393588602,1.179645688115274,['ELK1'],0.9993770810362673,0,0,1
190,Vitamin B12 Disorders WP4271,0.48545497952441247,1.632346393588602,1.179645688115274,['TCN1'],0.9993770810362673,0,0,1
191,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.4944009518776869,1.2436974789915967,0.876071010362953,"['POSTN', 'ANGPT2']",0.9993770810362673,0,0,2
192,Lung fibrosis WP3624,0.49572026391264323,1.1522537650207272,0.8085865846570559,"['IL5', 'HMOX1', 'FGF1']",0.9993770810362673,0,0,3
193,Phosphodiesterases in neuronal function WP4222,0.4959868187528277,1.1113981762917933,0.7793189892568201,"['ADCY10', 'PDE10A', 'PDE6C', 'PDE5A']",0.9993770810362673,0,0,4
194,miRNA regulation of DNA damage response WP1530,0.5096737806833623,1.0703350473930178,0.7213891286156678,"['CDKN1A', 'GADD45B', 'GADD45A', 'CYCS', 'BAX']",0.9993770810362673,0,0,5
195,Prostaglandin Synthesis and Regulation WP98,0.5138610755298375,1.1192557665349816,0.7452030984895048,"['HSD11B1', 'HSD11B2', 'S100A6']",0.9993770810362673,0,0,3
196,Dopamine metabolism WP2436,0.5220870634494046,1.4508756307509647,0.9429544200857284,['TYR'],0.9993770810362673,0,0,1
197,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.5220870634494046,1.4508756307509647,0.9429544200857284,['MAFF'],0.9993770810362673,0,0,1
198,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.5220870634494046,1.4508756307509647,0.9429544200857284,['FN1'],0.9993770810362673,0,0,1
199,Neuroinflammation WP4919,0.5220870634494046,1.4508756307509647,0.9429544200857284,['FOS'],0.9993770810362673,0,0,1
200,Selective expression of chemokine receptors during T-cell polarization WP4494,0.5220870634494046,1.4508756307509647,0.9429544200857284,['IL5'],0.9993770810362673,0,0,1
201,TCA cycle in senescence WP5050,0.5220870634494046,1.4508756307509647,0.9429544200857284,['GOT1'],0.9993770810362673,0,0,1
202,Cannabinoid receptor signaling WP3869,0.5396439015514458,1.1353948694102147,0.7003635548596288,"['CYP2C19', 'CYP3A4']",0.9993770810362673,0,0,2
203,Ethanol effects on histone modifications WP3996,0.5396439015514458,1.1353948694102147,0.7003635548596288,"['ALDH1A3', 'AHCY']",0.9993770810362673,0,0,2
204,Ovarian infertility WP34,0.5396439015514458,1.1353948694102147,0.7003635548596288,"['EGR1', 'PRLR']",0.9993770810362673,0,0,2
205,Striated Muscle Contraction Pathway WP383,0.5396439015514458,1.1353948694102147,0.7003635548596288,"['MYOM1', 'ACTG1']",0.9993770810362673,0,0,2
206,Aryl Hydrocarbon Receptor Netpath WP2586,0.5490618397214557,1.0586107963449622,0.6346839663487783,"['CDKN1A', 'HSP90AA1', 'LPL']",0.9993770810362673,0,0,3
207,Copper homeostasis WP3286,0.5490618397214557,1.0586107963449622,0.6346839663487783,"['SCO2', 'COX17', 'ATOX1']",0.9993770810362673,0,0,3
208,Alanine and aspartate metabolism WP106,0.5561133411508199,1.305699020480855,0.7661621900857651,['GOT1'],0.9993770810362673,0,0,1
209,Biogenic Amine Synthesis WP550,0.5561133411508199,1.305699020480855,0.7661621900857651,['TPH1'],0.9993770810362673,0,0,1
210,Biomarkers for urea cycle disorders WP4583,0.5561133411508199,1.305699020480855,0.7661621900857651,['GOT1'],0.9993770810362673,0,0,1
211,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.5561133411508199,1.305699020480855,0.7661621900857651,['LPL'],0.9993770810362673,0,0,1
212,"NAD metabolism, sirtuins and aging WP3630",0.5561133411508199,1.305699020480855,0.7661621900857651,['ROS1'],0.9993770810362673,0,0,1
213,Osteoblast Signaling WP322,0.5561133411508199,1.305699020480855,0.7661621900857651,['COL1A1'],0.9993770810362673,0,0,1
214,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.5561133411508199,1.305699020480855,0.7661621900857651,['IGLL1'],0.9993770810362673,0,0,1
215,Purine metabolism WP4792,0.5561133411508199,1.305699020480855,0.7661621900857651,['APRT'],0.9993770810362673,0,0,1
216,7-oxo-C and 7beta-HC pathways WP5064,0.5611898566404143,1.08801247771836,0.6285404621253637,"['HSD11B1', 'HSD11B2']",0.9993770810362673,0,0,2
217,White fat cell differentiation WP4149,0.5611898566404143,1.08801247771836,0.6285404621253637,"['EGR2', 'DDIT3']",0.9993770810362673,0,0,2
218,Non-small cell lung cancer WP4255,0.5628790763557107,1.0041933044614009,0.5771003104230114,"['CDKN1A', 'GADD45B', 'GADD45A', 'CYCS', 'BAX']",0.9993770810362673,0,0,5
219,Hepatitis B infection WP4666,0.564346829556442,0.9871952368391302,0.5647608412629682,"['EGR2', 'CDKN1A', 'EGR3', 'ATP6AP1', 'SLC10A1', 'CYCS', 'BAX', 'FOS', 'ELK1']",0.9993770810362673,0,0,9
220,Nanoparticle-mediated activation of receptor signaling WP2643,0.5820034860486247,1.0444206773618538,0.5653228142751879,"['COL1A1', 'FN1']",0.9993770810362673,0,0,2
221,Eukaryotic Transcription Initiation WP405,0.5827148333991041,1.0041858230975091,0.5423179333593754,"['TAF13', 'POLR2I', 'POLR2K']",0.9993770810362673,0,0,3
222,Folate Metabolism WP176,0.5827148333991041,1.0041858230975091,0.5423179333593754,"['AHCY', 'GPX4', 'RFK']",0.9993770810362673,0,0,3
223,Integrated Cancer Pathway WP1971,0.5827148333991041,1.0041858230975091,0.5423179333593754,"['CDKN1A', 'CDKN2B', 'BAX']",0.9993770810362673,0,0,3
224,Notch Signaling Pathway Netpath WP61,0.5852194850961498,0.9851752021563343,0.5278256569723618,"['CDKN1A', 'MAML2', 'HEY1', 'DLL3']",0.9993770810362673,0,0,4
225,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.5877190220098214,1.1869181575325831,0.6308544771459582,['DKK1'],0.9993770810362673,0,0,1
226,Cancer immunotherapy by CTLA4 blockade WP4582,0.5877190220098214,1.1869181575325831,0.6308544771459582,['CD80'],0.9993770810362673,0,0,1
227,PDGFR-beta pathway WP3972,0.6020798402340154,1.0041820924173865,0.5094870657227093,"['FOS', 'ELK1']",0.9993770810362673,0,0,2
228,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.6020798402340154,1.0041820924173865,0.5094870657227093,"['COL1A1', 'ADAMTS2']",0.9993770810362673,0,0,2
229,Osteoblast differentiation WP4787,0.6056013945154738,0.9515722918531782,0.47724516713397785,"['PRKCH', 'HEY1', 'WNT8A', 'FGF1', 'FGFR4', 'FGF10', 'DLL3']",0.9993770810362673,0,0,7
230,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.617076162084826,1.08793410507569,0.5252141401690341,['POSTN'],0.9993770810362673,0,0,1
231,Ganglio Sphingolipid Metabolism WP1423,0.617076162084826,1.08793410507569,0.5252141401690341,['FUT1'],0.9993770810362673,0,0,1
232,Glutathione metabolism WP100,0.617076162084826,1.08793410507569,0.5252141401690341,['GPX4'],0.9993770810362673,0,0,1
233,Homologous recombination WP186,0.617076162084826,1.08793410507569,0.5252141401690341,['POLD4'],0.9993770810362673,0,0,1
234,Nephrogenesis WP5052,0.617076162084826,1.08793410507569,0.5252141401690341,['PAX2'],0.9993770810362673,0,0,1
235,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.617076162084826,1.08793410507569,0.5252141401690341,['ANAPC11'],0.9993770810362673,0,0,1
236,G1 to S cell cycle control WP45,0.639307458131511,0.9157894736842105,0.4096965401188335,"['CDKN1A', 'CDKN2B', 'GADD45A', 'RPA3']",0.9993770810362673,0,0,4
237,GABA receptor Signaling WP4159,0.6400223624277414,0.9323274764451235,0.41605315200483456,"['GABRE', 'AP2M1']",0.9993770810362673,0,0,2
238,Phytochemical activity on NRF2 transcriptional activation WP3,0.6443445981954067,1.004178368381396,0.44135808880191746,['HMOX1'],0.9993770810362673,0,0,1
239,Riboflavin and CoQ disorders WP5037,0.6443445981954067,1.004178368381396,0.44135808880191746,['RFK'],0.9993770810362673,0,0,1
240,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.6450387477276421,0.910524241229799,0.399214700783225,"['XBP1', 'MAP1LC3A', 'DDIT3']",0.9993770810362673,0,0,3
241,Regulation of Actin Cytoskeleton WP51,0.6552370508785873,0.9100427573261028,0.384728037174907,"['CFL2', 'TMSB4X', 'F2R', 'FN1', 'BRK1', 'FGF1', 'FGFR4', 'ACTG1', 'FGF10']",0.9993770810362673,0,0,9
242,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.6645573584294313,0.8846246973365618,0.3614878049816037,"['EGR1', 'FOS', 'CGA', 'TSHR']",0.9993770810362673,0,0,4
243,Biomarkers for pyrimidine metabolism disorders WP4584,0.6696728143649309,0.9323877369291439,0.37385580243583155,['NT5C'],0.9993770810362673,0,0,1
244,Dopaminergic Neurogenesis WP2855,0.6696728143649309,0.9323877369291439,0.37385580243583155,['SLC18A2'],0.9993770810362673,0,0,1
245,miRNAs involved in DNA damage response WP1545,0.6696728143649309,0.9323877369291439,0.37385580243583155,['CDKN1A'],0.9993770810362673,0,0,1
246,Cytosolic DNA-sensing pathway WP4655,0.6736221653056174,0.8699375557537913,0.3437000716034021,"['IL18', 'POLR2K', 'POLR2L']",0.9993770810362673,0,0,3
247,Fatty acid beta-oxidation WP143,0.6750555958735311,0.8700534759358288,0.3418964116184131,"['TPI1', 'LPL']",0.9993770810362673,0,0,2
248,Melatonin metabolism and effects WP3298,0.6750555958735311,0.8700534759358288,0.3418964116184131,"['PER2', 'CYP2C19']",0.9993770810362673,0,0,2
249,Neural Crest Cell Migration during Development WP4564,0.6750555958735311,0.8700534759358288,0.3418964116184131,"['BDNF', 'FOS']",0.9993770810362673,0,0,2
250,TGF-beta Signaling Pathway WP366,0.6815325176027314,0.8842111657857967,0.33901656513340106,"['CDKN1A', 'CDKN2B', 'PARD6A', 'CITED1', 'FN1', 'NEDD9', 'FOS', 'JUNB']",0.9993770810362673,0,0,8
251,Acute viral myocarditis WP4298,0.6885737683692402,0.855503512880562,0.3192164408064454,"['ENDOG', 'CD80', 'CYCS', 'BAX']",0.9993770810362673,0,0,4
252,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.6885737683692402,0.855503512880562,0.3192164408064454,"['PSMD8', 'TUBB8', 'HSPA8', 'STUB1']",0.9993770810362673,0,0,4
253,Type 2 papillary renal cell carcinoma WP4241,0.6915058444182762,0.841929733770341,0.3105741352238103,"['CDKN1A', 'ELOB']",0.9993770810362673,0,0,2
254,Cancer immunotherapy by PD-1 blockade WP4585,0.6931987479711114,0.8701691896705254,0.3188635163651823,['PDCD1LG2'],0.9993770810362673,0,0,1
255,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.6931987479711114,0.8701691896705254,0.3188635163651823,['SYTL5'],0.9993770810362673,0,0,1
256,Glycosaminoglycan degradation WP4815,0.6931987479711114,0.8701691896705254,0.3188635163651823,['HPSE2'],0.9993770810362673,0,0,1
257,NOTCH1 regulation of endothelial cell calcification WP3413,0.6931987479711114,0.8701691896705254,0.3188635163651823,['DLL3'],0.9993770810362673,0,0,1
258,Allograft Rejection WP2328,0.7004731002184995,0.8328050562757416,0.2964780293732608,"['IL5', 'CD80', 'HLA-C']",0.9993770810362673,0,0,3
259,p38 MAPK Signaling Pathway WP400,0.7072627294680319,0.8155637254901961,0.2824730004479757,"['DDIT3', 'ELK1']",0.9993770810362673,0,0,2
260,Parkinson's disease pathway WP2371,0.7072627294680319,0.8155637254901961,0.2824730004479757,"['PINK1', 'CYCS']",0.9993770810362673,0,0,2
261,Signaling of Hepatocyte Growth Factor Receptor WP313,0.7072627294680319,0.8155637254901961,0.2824730004479757,"['FOS', 'ELK1']",0.9993770810362673,0,0,2
262,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.713253479239979,0.8153991971454059,0.2755384009414512,"['BEX3', 'CDKN1A', 'F2R']",0.9993770810362673,0,0,3
263,Translation Factors WP107,0.713253479239979,0.8153991971454059,0.2755384009414512,"['EIF4A2', 'EEF1B2', 'EEF1G']",0.9993770810362673,0,0,3
264,15q13.3 copy number variation syndrome WP4942,0.7150505379330717,0.8157279608192342,0.27359683549086444,['GOLGA8H'],0.9993770810362673,0,0,1
265,BMP Signaling Pathway in Eyelid Development WP3927,0.7150505379330717,0.8157279608192342,0.27359683549086444,['FGF10'],0.9993770810362673,0,0,1
266,Canonical and non-canonical TGF-B signaling WP3874,0.7150505379330717,0.8157279608192342,0.27359683549086444,['LOXL1'],0.9993770810362673,0,0,1
267,Complement Activation WP545,0.7150505379330717,0.8157279608192342,0.27359683549086444,['MASP2'],0.9993770810362673,0,0,1
268,"GPCRs, Class B Secretin-like WP334",0.7150505379330717,0.8157279608192342,0.27359683549086444,['ADGRG2'],0.9993770810362673,0,0,1
269,Pyrimidine metabolism and related diseases WP4225,0.7150505379330717,0.8157279608192342,0.27359683549086444,['NT5C'],0.9993770810362673,0,0,1
270,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.7150505379330717,0.8157279608192342,0.27359683549086444,['FN1'],0.9993770810362673,0,0,1
271,Neural Crest Cell Migration in Cancer WP4565,0.7223415430998813,0.7907956571058176,0.2572119816436358,"['BDNF', 'FOS']",0.9993770810362673,0,0,2
272,Pancreatic adenocarcinoma pathway WP4263,0.7319814092906535,0.8150692582663092,0.2543017410174544,"['CDKN1A', 'GADD45B', 'GADD45A', 'BAX', 'DUSP6']",0.9993770810362673,0,0,5
273,Apoptosis Modulation by HSP70 WP384,0.7353472202199131,0.7676915824210361,0.23599797542014855,['CYCS'],0.9993770810362673,0,0,1
274,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.7353472202199131,0.7676915824210361,0.23599797542014855,['MAP1LC3A'],0.9993770810362673,0,0,1
275,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.7353472202199131,0.7676915824210361,0.23599797542014855,['CD80'],0.9993770810362673,0,0,1
276,Methionine De Novo and Salvage Pathway WP3580,0.7353472202199131,0.7676915824210361,0.23599797542014855,['AHCY'],0.9993770810362673,0,0,1
277,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.7353472202199131,0.7676915824210361,0.23599797542014855,['FN1'],0.9993770810362673,0,0,1
278,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.7353472202199131,0.7676915824210361,0.23599797542014855,['IDH3B'],0.9993770810362673,0,0,1
279,Transcription factor regulation in adipogenesis WP3599,0.7353472202199131,0.7676915824210361,0.23599797542014855,['LEP'],0.9993770810362673,0,0,1
280,IL-2 signaling pathway WP49,0.7367589121101705,0.7674845339205201,0.23446235070199645,"['CISH', 'FOS']",0.9993770810362673,0,0,2
281,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.7367589121101705,0.7674845339205201,0.23446235070199645,"['BDNF', 'GABRE']",0.9993770810362673,0,0,2
282,Modulators of TCR signaling and T cell activation WP5072,0.7375428890424743,0.7826761819803747,0.23827092236136138,"['NDUFB10', 'CD5', 'ELOB']",0.9993770810362673,0,0,3
283,Development of ureteric collection system WP5053,0.750532531246171,0.7455054749172396,0.21393940794002494,"['SPRY1', 'PAX2']",0.9993770810362673,0,0,2
284,Hedgehog Signaling Pathway WP4249,0.750532531246171,0.7455054749172396,0.21393940794002494,"['EVC', 'HHIP']",0.9993770810362673,0,0,2
285,IL-5 signaling pathway WP127,0.750532531246171,0.7455054749172396,0.21393940794002494,"['FOS', 'ELK1']",0.9993770810362673,0,0,2
286,Vitamin D-sensitive calcium signaling in depression WP4698,0.750532531246171,0.7455054749172396,0.21393940794002494,"['TPH1', 'GPX4']",0.9993770810362673,0,0,2
287,DNA Repair Pathways Full Network WP4946,0.7510947562817134,0.8147381378692927,0.233197170199601,"['POLE4', 'POLD4', 'FEN1', 'NEIL2', 'CENPX', 'RPA3', 'POLE3']",0.9993770810362673,0,0,7
288,Ebstein-Barr virus LMP1 signaling WP262,0.7541993741808473,0.7249925794004155,0.20451933651413579,['HSP90AA1'],0.9993770810362673,0,0,1
289,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.7541993741808473,0.7249925794004155,0.20451933651413579,['LDHA'],0.9993770810362673,0,0,1
290,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.7541993741808473,0.7249925794004155,0.20451933651413579,['BAX'],0.9993770810362673,0,0,1
291,miRNA targets in ECM and membrane receptors WP2911,0.7541993741808473,0.7249925794004155,0.20451933651413579,['FN1'],0.9993770810362673,0,0,1
292,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.7541993741808473,0.7249925794004155,0.20451933651413579,['ELK1'],0.9993770810362673,0,0,1
293,Prolactin Signaling Pathway WP2037,0.762872606333492,0.7670693277310925,0.2076182257360309,"['CISH', 'FOS', 'ELK1', 'PRLR']",0.9993770810362673,0,0,4
294,ATM Signaling Pathway WP2516,0.7636809273748546,0.7247474747474747,0.19539569612295485,"['CDKN1A', 'GADD45A']",0.9993770810362673,0,0,2
295,Fas ligand pathway and stress induction of heat shock proteins WP314,0.7636809273748546,0.7247474747474747,0.19539569612295485,"['CYCS', 'ACTG1']",0.9993770810362673,0,0,2
296,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.7636809273748546,0.7247474747474747,0.19539569612295485,"['CISH', 'RELB']",0.9993770810362673,0,0,2
297,One-carbon metabolism WP241,0.7717097226591556,0.6867882082767024,0.1779789709743717,['AHCY'],0.9993770810362673,0,0,1
298,Purine metabolism and related disorders WP4224,0.7717097226591556,0.6867882082767024,0.1779789709743717,['APRT'],0.9993770810362673,0,0,1
299,Triacylglyceride synthesis WP325,0.7717097226591556,0.6867882082767024,0.1779789709743717,['LPL'],0.9993770810362673,0,0,1
300,Urea cycle and metabolism of amino groups WP497,0.7717097226591556,0.6867882082767024,0.1779789709743717,['CKM'],0.9993770810362673,0,0,1
301,Vitamin D in inflammatory diseases WP4482,0.7717097226591556,0.6867882082767024,0.1779789709743717,['DUSP1'],0.9993770810362673,0,0,1
302,PDGF Pathway WP2526,0.7762232516128278,0.7051115286409404,0.1786154007719171,"['FOS', 'ELK1']",0.9993770810362673,0,0,2
303,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.7879736897481552,0.6524042742653606,0.1554617918171412,['HIST1H3E'],0.9993770810362673,0,0,1
304,Glycerolipids and Glycerophospholipids WP4722,0.7879736897481552,0.6524042742653606,0.1554617918171412,['CDIPT'],0.9993770810362673,0,0,1
305,IL-7 signaling pathway WP205,0.7879736897481552,0.6524042742653606,0.1554617918171412,['IL7'],0.9993770810362673,0,0,1
306,Statin inhibition of cholesterol production WP430,0.7879736897481552,0.6524042742653606,0.1554617918171412,['LPL'],0.9993770810362673,0,0,1
307,DNA Replication WP466,0.7881790969575969,0.6865090533821184,0.1634097050414348,"['POLD4', 'RPA3']",0.9993770810362673,0,0,2
308,Nephrotic syndrome WP4758,0.7881790969575969,0.6865090533821184,0.1634097050414348,"['TRPC6', 'PAX2']",0.9993770810362673,0,0,2
309,NO/cGMP/PKG mediated Neuroprotection WP4008,0.7881790969575969,0.6865090533821184,0.1634097050414348,"['NEFL', 'CYCS']",0.9993770810362673,0,0,2
310,Apoptosis Modulation and Signaling WP1772,0.7987027906355536,0.7242559523809524,0.16278838795303854,"['ENDOG', 'CYCS', 'BAX', 'FOS']",0.9993770810362673,0,0,4
311,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.8006749639824638,0.698531285841723,0.15528364598442926,"['IFI27L2', 'PRKCH', 'RELB']",0.9993770810362673,0,0,3
312,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.8030799188582829,0.6212950006360514,0.13625064266593565,['TRPA1'],0.9993770810362673,0,0,1
313,NAD+ biosynthetic pathways WP3645,0.8030799188582829,0.6212950006360514,0.13625064266593565,['ACMSD'],0.9993770810362673,0,0,1
314,Nanoparticle triggered autophagic cell death WP2509,0.8030799188582829,0.6212950006360514,0.13625064266593565,['MAP1LC3A'],0.9993770810362673,0,0,1
315,NRF2-ARE regulation WP4357,0.8030799188582829,0.6212950006360514,0.13625064266593565,['HMOX1'],0.9993770810362673,0,0,1
316,Alzheimer's disease WP2059,0.8069440538485837,0.7142857142857143,0.15321495657240725,"['ATP5MD', 'LPL', 'CYCS', 'CALM3']",0.9993770810362673,0,0,4
317,p53 transcriptional gene network WP4963,0.8098564254867968,0.6862294004413353,0.14472461362833153,"['CDKN1A', 'GADD45A', 'BAX']",0.9993770810362673,0,0,3
318,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.810410995328859,0.6520944741532977,0.13707923021740284,"['MAP1LC3A', 'ATG101']",0.9993770810362673,0,0,2
319,PI3K-Akt signaling pathway WP4172,0.8105133185052761,0.8197504192842321,0.17221932070836496,"['CDKN1A', 'HSP90AA1', 'ANGPT2', 'LAMB3', 'BDNF', 'F2R', 'FN1', 'FGF1', 'PRLR', 'COL1A1', 'GNG3', 'LPAR6', 'IL7', 'COL6A6', 'FGFR4', 'FGF10']",0.9993770810362673,0,0,16
320,EPO Receptor Signaling WP581,0.8171107545050953,0.5930138427912248,0.11977731008763534,['CISH'],0.9993770810362673,0,0,1
321,miRNA regulation of p53 pathway in prostate cancer WP3982,0.8171107545050953,0.5930138427912248,0.11977731008763534,['BAX'],0.9993770810362673,0,0,1
322,Trans-sulfuration and one-carbon metabolism WP2525,0.8171107545050953,0.5930138427912248,0.11977731008763534,['AHCY'],0.9993770810362673,0,0,1
323,AMP-activated protein kinase (AMPK) signaling WP1403,0.8186779088458687,0.6743517179857885,0.13491387042042696,"['CDKN1A', 'LEP', 'LEPR']",0.9993770810362673,0,0,3
324,Netrin-UNC5B signaling pathway WP4747,0.8207271072271624,0.6361462545106734,0.12567999017013126,"['COL1A1', 'SELE']",0.9993770810362673,0,0,2
325,Cell cycle WP179,0.8234333666967729,0.7305769648738568,0.14193112109275016,"['CDKN1A', 'CDKN2B', 'GADD45B', 'GADD45A', 'ANAPC11', 'YWHAH']",0.9993770810362673,0,0,6
326,Gastric Cancer Network 1 WP2361,0.8301426890077706,0.5671919160633396,0.10558713035826066,['GATD3A'],0.9993770810362673,0,0,1
327,miRNAs involvement in the immune response in sepsis WP4329,0.8301426890077706,0.5671919160633396,0.10558713035826066,['RELB'],0.9993770810362673,0,0,1
328,MTHFR deficiency WP4288,0.8301426890077706,0.5671919160633396,0.10558713035826066,['CYCS'],0.9993770810362673,0,0,1
329,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.8301426890077706,0.5671919160633396,0.10558713035826066,['CYP3A4'],0.9993770810362673,0,0,1
330,Physiological and pathological hypertrophy of the heart WP1528,0.8301426890077706,0.5671919160633396,0.10558713035826066,['FOS'],0.9993770810362673,0,0,1
331,Wnt/beta-catenin signaling pathway in leukemia WP3658,0.8301426890077706,0.5671919160633396,0.10558713035826066,['DKK1'],0.9993770810362673,0,0,1
332,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.830536632625543,0.6209574738986504,0.11530139676095962,"['CD160', 'CXCL17']",0.9993770810362673,0,0,2
333,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.8371940971014555,0.6769944341372913,0.12030146358682818,"['MC4R', 'POMC', 'UCP1', 'TSHR']",0.9993770810362673,0,0,4
334,Cell migration and invasion through p75NTR WP4561,0.8422467784535145,0.5435218165627783,0.09331303297286671,['BDNF'],0.9993770810362673,0,0,1
335,Glycosylation and related congenital defects WP4521,0.8422467784535145,0.5435218165627783,0.09331303297286671,['DPM3'],0.9993770810362673,0,0,1
336,Endoderm differentiation WP2853,0.8475219691598633,0.704056471498332,0.11647805905767332,"['DUSP4', 'DUSP5', 'DUSP2', 'WNT8A', 'DKK1', 'NODAL']",0.9993770810362673,0,0,6
337,ESC Pluripotency Pathways WP3931,0.8479624650014049,0.6856685950801937,0.11307971536078268,"['FOS', 'FGF1', 'FGFR4', 'ELK1', 'FGF10']",0.9993770810362673,0,0,5
338,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.853489028639632,0.5217453250222618,0.08265624643175161,['CDKN1A'],0.9993770810362673,0,0,1
339,Gastric Cancer Network 2 WP2363,0.853489028639632,0.5217453250222618,0.08265624643175161,['S100A6'],0.9993770810362673,0,0,1
340,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.853489028639632,0.5217453250222618,0.08265624643175161,['PRLR'],0.9993770810362673,0,0,1
341,SARS-CoV-2 mitochondrial interactions WP5038,0.853489028639632,0.5217453250222618,0.08265624643175161,['PHB'],0.9993770810362673,0,0,1
342,Toll-like Receptor Signaling related to MyD88 WP3858,0.853489028639632,0.5217453250222618,0.08265624643175161,['RELB'],0.9993770810362673,0,0,1
343,Calcium Regulation in the Cardiac Cell WP536,0.8537433051652629,0.7121125223813787,0.11260258595247996,"['RGS4', 'GNG3', 'PRKCH', 'PLN', 'CALM3', 'ADRA1D', 'YWHAH']",0.9993770810362673,0,0,7
344,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.8571222471519709,0.5794414735591206,0.08933522990082547,"['FOS', 'ELK1']",0.9993770810362673,0,0,2
345,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.8571222471519709,0.5794414735591206,0.08933522990082547,"['ARC', 'BDNF']",0.9993770810362673,0,0,2
346,TYROBP causal network in microglia WP3945,0.8571222471519709,0.5794414735591206,0.08933522990082547,"['IL18', 'SAMSN1']",0.9993770810362673,0,0,2
347,Pathways Regulating Hippo Signaling WP4540,0.863371012212256,0.6433862433862434,0.09452036869344672,"['PRKCH', 'PRKD3', 'FGFR4', 'CDH17']",0.9993770810362673,0,0,4
348,IL17 signaling pathway WP2112,0.8639307536047343,0.5016439482156312,0.07337177807878761,['IL17RE'],0.9993770810362673,0,0,1
349,IL-4 signaling pathway WP395,0.8651004924416742,0.5668061691079593,0.08213565669684969,"['FOS', 'ELK1']",0.9993770810362673,0,0,2
350,Gastrin signaling pathway WP4659,0.8707328802524924,0.6577842770872262,0.09105051992767249,"['EGR1', 'CDKN1A', 'PRKCH', 'FOS', 'ELK1']",0.9993770810362673,0,0,5
351,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.872668001840307,0.5547085371866348,0.07555135334805854,"['IL5', 'FOS']",0.9993770810362673,0,0,2
352,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.8732026717258567,0.6903434524293969,0.09360200817368254,"['SHC4', 'EGR1', 'EGR2', 'RAB3A', 'BDNF', 'FOS', 'ELK1']",0.9993770810362673,0,0,7
353,Autophagy WP4923,0.8736289089205951,0.48303156228356586,0.06525736255624269,['ATG101'],0.9993770810362673,0,0,1
354,Endothelin Pathways WP2197,0.8736289089205951,0.48303156228356586,0.06525736255624269,['ADCY10'],0.9993770810362673,0,0,1
355,Glycerophospholipid Biosynthetic Pathway WP2533,0.8736289089205951,0.48303156228356586,0.06525736255624269,['CDIPT'],0.9993770810362673,0,0,1
356,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.8736289089205951,0.48303156228356586,0.06525736255624269,['FGF1'],0.9993770810362673,0,0,1
357,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.8736289089205951,0.48303156228356586,0.06525736255624269,['BAX'],0.9993770810362673,0,0,1
358,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.8791251742699715,0.7521182339364157,0.09689387740427367,"['CDKN1A', 'HSP90AA1', 'ANGPT2', 'LAMB3', 'F2R', 'FN1', 'HIF3A', 'FGF1', 'PRLR', 'COL1A1', 'GNG3', 'LPAR6', 'FGFR4', 'FGF10']",0.9993770810362673,0,0,14
359,RANKL/RANK signaling pathway WP2018,0.8798427703423465,0.5431149732620321,0.06952526520740193,"['FOS', 'RELB']",0.9993770810362673,0,0,2
360,TNF-alpha signaling pathway WP231,0.8805606937590066,0.6202806122448979,0.07889747476545968,"['HSP90AA1', 'RFK', 'BAX', 'SELE']",0.9993770810362673,0,0,4
361,Sphingolipid pathway WP1422,0.8826364012267084,0.46574863248950515,0.05814496274927193,['SERINC1'],0.9993770810362673,0,0,1
362,Pathogenic Escherichia coli infection WP2272,0.8866423141724322,0.5319946160282295,0.06400620417723793,"['TUBB8', 'ACTG1']",0.9993770810362673,0,0,2
363,Genes controlling nephrogenesis WP4823,0.8910023760648371,0.4496576288881383,0.05189417072041204,['PAX2'],0.9993770810362673,0,0,1
364,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.8910023760648371,0.4496576288881383,0.05189417072041204,['LPL'],0.9993770810362673,0,0,1
365,Prion disease pathway WP3995,0.8910023760648371,0.4496576288881383,0.05189417072041204,['ELK1'],0.9993770810362673,0,0,1
366,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.8930836477509191,0.521319073083779,0.05894817087047801,"['CDKN1A', 'JUNB']",0.9993770810362673,0,0,2
367,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.8987724845829379,0.4346393588601959,0.046387038846966676,['FOS'],0.9993770810362673,0,0,1
368,miRNA regulation of prostate cancer signaling pathways WP3981,0.8987724845829379,0.4346393588601959,0.046387038846966676,['CDKN1A'],0.9993770810362673,0,0,1
369,Neovascularisation processes WP4331,0.8987724845829379,0.4346393588601959,0.046387038846966676,['RELB'],0.9993770810362673,0,0,1
370,Alpha 6 Beta 4 signaling pathway WP244,0.9059891320817894,0.42059000947921754,0.041523997209725834,['LAMB3'],0.9993770810362673,0,0,1
371,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9059891320817894,0.42059000947921754,0.041523997209725834,['SUPT4H1'],0.9993770810362673,0,0,1
372,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9104206743492071,0.4917095483133219,0.04614620688106797,"['ADAMTS1', 'TIMP3']",0.9993770810362673,0,0,2
373,Endochondral Ossification WP474,0.9104206743492071,0.4917095483133219,0.04614620688106797,"['ADAMTS1', 'TIMP3']",0.9993770810362673,0,0,2
374,Disruption of postsynaptic signaling by CNV WP4875,0.9126917086750725,0.4074187444345503,0.037220604711617845,['ARC'],0.9993770810362673,0,0,1
375,MAPK Cascade WP422,0.9126917086750725,0.4074187444345503,0.037220604711617845,['ELK1'],0.9993770810362673,0,0,1
376,Nuclear receptors WP170,0.9126917086750725,0.4074187444345503,0.037220604711617845,['NR4A1'],0.9993770810362673,0,0,1
377,Target Of Rapamycin (TOR) Signaling WP1471,0.9126917086750725,0.4074187444345503,0.037220604711617845,['RRAGA'],0.9993770810362673,0,0,1
378,Kit receptor signaling pathway WP304,0.9155887691055261,0.48257080610021785,0.04255693356402221,"['FOS', 'JUNB']",0.9993770810362673,0,0,2
379,MET in type 1 papillary renal cell carcinoma WP4205,0.9204757544061573,0.4737643817857722,0.0392583046358239,"['CDKN1A', 'RPL11']",0.9993770810362673,0,0,2
380,7q11.23 copy number variation syndrome WP4932,0.9213219934727828,0.5599078341013825,0.04588203432591144,"['CLDN5', 'ATP5MC3', 'ATP5F1E', 'ATP5MC1']",0.9993770810362673,0,0,4
381,Bladder cancer WP2828,0.924698402766359,0.38340055523545125,0.030015526829192687,['CDKN1A'],0.9993770810362673,0,0,1
382,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.924698402766359,0.38340055523545125,0.030015526829192687,['MAP1LC3A'],0.9993770810362673,0,0,1
383,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.924698402766359,0.38340055523545125,0.030015526829192687,['CALM3'],0.9993770810362673,0,0,1
384,Vitamin B12 metabolism WP1533,0.924698402766359,0.38340055523545125,0.030015526829192687,['TCN1'],0.9993770810362673,0,0,1
385,Amino Acid metabolism WP3925,0.9267337210703452,0.5140030048359078,0.039109976031097546,"['TPH1', 'LDHA', 'GOT1']",0.9993770810362673,0,0,3
386,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.9300680768778957,0.3724208116015774,0.02699957576681052,['PRKCH'],0.9993770810362673,0,0,1
387,Male infertility WP4673,0.9318371265378574,0.5422991071428571,0.0382848183217592,"['CYP26B1', 'MSH4', 'TEX15', 'ETV5']",0.9993770810362673,0,0,4
388,Mesodermal commitment pathway WP2857,0.9320936566486696,0.5706457833592022,0.04012894101006523,"['ARL4A', 'BHLHE40', 'RPL38', 'DKK1', 'NODAL']",0.9993770810362673,0,0,5
389,Glioblastoma signaling pathways WP2261,0.9340901944329112,0.5007548205585672,0.03414260413496367,"['CDKN1A', 'CDKN2B', 'PRKCH']",0.9993770810362673,0,0,3
390,G13 Signaling Pathway WP524,0.9350551499414012,0.362051053725141,0.024311644094670515,['CFL2'],0.9993770810362673,0,0,1
391,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.9350551499414012,0.362051053725141,0.024311644094670515,['RELB'],0.9993770810362673,0,0,1
392,Neural Crest Differentiation WP2064,0.9375073179220816,0.49438227622263126,0.03190284195805518,"['MIA', 'WNT8A', 'DLL3']",0.9993770810362673,0,0,3
393,Retinoblastoma gene in cancer WP2446,0.9375073179220816,0.49438227622263126,0.03190284195805518,"['CDKN1A', 'H2AFZ', 'RPA3']",0.9993770810362673,0,0,3
394,Regulation of toll-like receptor signaling pathway WP1449,0.9410643513951009,0.5257575757575758,0.03193648966315594,"['CISH', 'CD80', 'PELI3', 'FOS']",0.9993770810362673,0,0,4
395,Glycogen Synthesis and Degradation WP500,0.9439885094852534,0.34294886816328446,0.019768013472920093,['CALM3'],0.9993770810362673,0,0,1
396,Pathways affected in adenoid cystic carcinoma WP3651,0.944629624819032,0.42698927559101135,0.024322316713657626,"['INSRR', 'FGFR4']",0.9993770810362673,0,0,2
397,Integrated breast cancer pathway WP1984,0.9463976857972218,0.5694214120627293,0.03137079880160851,"['PLK3', 'GADD45A', 'RHO', 'BAX', 'PHB', 'FAU']",0.9993770810362673,0,0,6
398,Common Pathways Underlying Drug Addiction WP2636,0.9479835979187942,0.33413247482704295,0.017848714819902477,['ACTG1'],0.9993770810362673,0,0,1
399,ErbB signaling pathway WP673,0.9496001360618658,0.4704276517309201,0.02432783313623062,"['SHC4', 'CDKN1A', 'ELK1']",0.9993770810362673,0,0,3
400,MECP2 and Associated Rett Syndrome WP3584,0.9509960941746849,0.41337747220100163,0.020770284825385538,"['BDNF', 'FKBP5']",0.9993770810362673,0,0,2
401,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9509960941746849,0.41337747220100163,0.020770284825385538,"['DUSP2', 'F2R']",0.9993770810362673,0,0,2
402,Hepatitis C and Hepatocellular Carcinoma WP3646,0.9516939549754813,0.3257569011576135,0.016128801333271024,['CDKN1A'],0.9993770810362673,0,0,1
403,IL-6 signaling pathway WP364,0.9516939549754813,0.3257569011576135,0.016128801333271024,['JUNB'],0.9993770810362673,0,0,1
404,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.9516939549754813,0.3257569011576135,0.016128801333271024,['ACTG1'],0.9993770810362673,0,0,1
405,G Protein Signaling Pathways WP35,0.9522625830030788,0.46479546323435705,0.022735218973978295,"['GNG3', 'PRKCH', 'PRKD3']",0.9993770810362673,0,0,3
406,Notch Signaling WP268,0.9551398566396856,0.3177898920574246,0.014585762359001905,['DLL3'],0.9993770810362673,0,0,1
407,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9566598219510305,0.4006033182503771,0.01774969694217675,"['CACNG4', 'ACTG1']",0.9993770810362673,0,0,2
408,IL-3 signaling pathway WP286,0.9583401362937612,0.3102022643429589,0.013199886724459344,['FOS'],0.9993770810362673,0,0,1
409,TGF-beta Receptor Signaling WP560,0.9583401362937612,0.3102022643429589,0.013199886724459344,['FOS'],0.9993770810362673,0,0,1
410,16p11.2 proximal deletion syndrome WP4949,0.959251166538151,0.3945065629557608,0.01641239370331954,"['ALDOA', 'CDIPT']",0.9993770810362673,0,0,2
411,Ebola Virus Pathway on Host WP4217,0.9603730532312823,0.4861815754339119,0.019658009549263663,"['CAV3', 'HLA-C', 'ACTG1', 'RELB']",0.9993770810362673,0,0,4
412,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9613122870952924,0.30296754954544514,0.01195387619574192,['DHCR24'],0.9993770810362673,0,0,1
413,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.9613122870952924,0.30296754954544514,0.01195387619574192,['ADCY10'],0.9993770810362673,0,0,1
414,One-carbon metabolism and related pathways WP3940,0.9613122870952924,0.30296754954544514,0.01195387619574192,['GPX4'],0.9993770810362673,0,0,1
415,Apoptosis WP254,0.9616935789318384,0.38859180035650626,0.015178164150425798,"['CYCS', 'BAX']",0.9993770810362673,0,0,2
416,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9616935789318384,0.38859180035650626,0.015178164150425798,"['FRAT2', 'DKK1']",0.9993770810362673,0,0,2
417,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.9640725575785782,0.2960616854205456,0.010832518112454368,['EIF4A2'],0.9993770810362673,0,0,1
418,Insulin Signaling WP481,0.9669455652215916,0.5267006720495092,0.017704030530956,"['EGR1', 'XBP1', 'PRKCH', 'FOS', 'ELK1', 'ARF6']",0.9993770810362673,0,0,6
419,Toll-like Receptor Signaling Pathway WP75,0.9682057905840806,0.37186147186147184,0.012015074978357727,"['CD80', 'FOS']",0.9993770810362673,0,0,2
420,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9690167516023094,0.283150722056603,0.008911710194841231,['FOS'],0.9993770810362673,0,0,1
421,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9705412278114862,0.49222113900398085,0.014718099331969001,"['CLDN5', 'FN1', 'WNT8A', 'FOXM1', 'DLL3']",0.9993770810362673,0,0,5
422,Ras signaling WP4223,0.9748296392979577,0.5059707734126339,0.0128984863409239,"['SHC4', 'GNG3', 'CALM3', 'FGFR4', 'ELK1', 'ARF6']",0.9993770810362673,0,0,6
423,Thermogenesis WP4321,0.9768131296953068,0.40214462418496005,0.00943427859530879,"['ADCY10', 'UCP1', 'ACTG1']",0.9993770810362673,0,0,3
424,DNA IR-damage and cellular response via ATR WP4016,0.9781795846159538,0.34236326109391124,0.0075532187635421475,"['FEN1', 'FOXM1']",0.9993770810362673,0,0,2
425,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9781795846159538,0.34236326109391124,0.0075532187635421475,"['FRAT2', 'DKK1']",0.9993770810362673,0,0,2
426,Focal Adhesion WP306,0.9786473412585031,0.5161908928135428,0.011141425403266958,"['COL1A1', 'SHC4', 'CAV3', 'LAMB3', 'FN1', 'ELK1', 'ACTG1']",0.9993770810362673,0,0,7
427,Hippo-Merlin Signaling Dysregulation WP4541,0.981536193848357,0.3861121170100953,0.007195735953909329,"['FGFR4', 'FOXM1', 'CDH17']",0.9993770810362673,0,0,3
428,DNA IR-double strand breaks and cellular response via ATM WP3959,0.9815490152062768,0.24563584737646801,0.0045745568150463035,['BAX'],0.9993770810362673,0,0,1
429,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.9819544056586753,0.3292944335386629,0.005996583941421377,"['SHC4', 'BAX']",0.9993770810362673,0,0,2
430,Ciliopathies WP4803,0.9856488829750825,0.46900661680712113,0.006779532977727744,"['DNAH11', 'RSPH4A', 'TMEM17', 'EVC', 'CCDC65', 'CCNQ']",0.9993770810362673,0,0,6
431,AGE/RAGE pathway WP2324,0.9862802204124601,0.2283357547921451,0.003154404920315529,['CYCS'],0.9993770810362673,0,0,1
432,EGF/EGFR signaling pathway WP437,0.9872791150790529,0.4355518769754875,0.005576147747946776,"['NDUFA13', 'FOS', 'ELK1', 'AP2M1', 'ARF6']",0.9993770810362673,0,0,5
433,B Cell Receptor Signaling Pathway WP23,0.9898549711596777,0.2954342894182466,0.003012496286914717,"['CD81', 'ELK1']",0.9993770810362673,0,0,2
434,Fragile X Syndrome  WP4549,0.9908012366878881,0.3448248640199569,0.0031866414628978273,"['ARC', 'BDNF', 'AP2M1']",0.9993770810362673,0,0,3
435,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9912039063217326,0.20650468557859475,0.0018244704814765313,['LPL'],0.9993770810362673,0,0,1
436,Integrin-mediated Cell Adhesion WP185,0.9921666584350467,0.28251181895683175,0.0022217247437824783,"['CAV3', 'RHO']",0.9993770810362673,0,0,2
437,DNA damage response (only ATM dependent) WP710,0.9943417026727516,0.26785747101089735,0.0015199213625018615,"['CDKN1A', 'BAX']",0.9993770810362673,0,0,2
438,Head and Neck Squamous Cell Carcinoma WP4674,0.9943612390157907,0.1884703240543575,0.0010657466872086776,['CDKN1A'],0.9993770810362673,0,0,1
439,Wnt signaling WP428,0.9946994160686217,0.2651060424169668,0.001408954276371678,"['FRAT2', 'DKK1']",0.9993770810362673,0,0,2
440,mRNA Processing WP411,0.9949215621629225,0.31657274645895433,0.0016117911773586065,"['LSM7', 'SNRPE', 'LSM2']",0.9993770810362673,0,0,3
441,Ectoderm Differentiation WP2858,0.9952173245182999,0.3139981583263791,0.0015053539792468196,"['STC1', 'VAX2', 'LY6E']",0.9993770810362673,0,0,3
442,Genes related to primary cilium development (based on CRISPR) WP4536,0.9953495456752586,0.25976827094474153,0.0012108581867217834,"['TMEM17', 'EVC']",0.9993770810362673,0,0,2
443,Joubert Syndrome WP4656,0.9954854225754504,0.1805802908875037,0.0008170895023979321,['TMEM17'],0.9993770810362673,0,0,1
444,T-cell receptor (TCR) signaling pathway WP69,0.9961074319844421,0.17567567567567569,0.0006851639066273298,['FOS'],0.9993770810362673,0,0,1
445,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9963855254580022,0.17332146037399823,0.0006276009143756246,['CISH'],0.9993770810362673,0,0,1
446,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9986767501194849,0.21800805883850866,0.00028867017134370836,"['LPL', 'CYP3A4']",0.9993770810362673,0,0,2
447,Wnt signaling pathway and pluripotency WP399,0.9988107562389377,0.14428613831997625,0.00017169350276585984,['PRKCH'],0.9993770810362673,0,0,1
448,Chemokine signaling pathway WP3929,0.9989870380671886,0.2108603973740272,0.00021370180985896017,"['SHC4', 'GNG3']",0.9993770810362673,0,0,2
449,Ciliary landscape WP4352,0.9993770810362673,0.31535125002724557,0.00019649948186150585,"['PSMD8', 'EXOSC4', 'NEFL', 'COPS7A', 'NEFM']",0.9993770810362673,0,0,5
